RAC supplies reference standards for 18 Axitinib impurities, including Axitinib Impurity 1 and Axitinib Impurity 2. Every lot is released with a certificate stating HPLC purity, MS and 1H NMR data, produced under ISO 17034:2016 (ANAB, AR-2832). All items are scheduled on synthesis, typically 3-4 weeks. Pharmacopoeial items follow the monograph numbering (EP, USP, BP); non-pharmacopoeial items are characterised against the drawn structure, and can be re-qualified against your own method on request.
| Padrão | CAS | Status | |
|---|---|---|---|
| Axitinib Impurity 1 | 1347304-18-0 | EM SÍNTESE | |
| Axitinib Impurity 2 | 1348536-59-3 | EM SÍNTESE | |
| Axitinib Impurity 3 | 885126-40-9 | EM SÍNTESE | |
| Axitinib Impurity 31 | — | EM SÍNTESE | |
| Axitinib Impurity 35 | 1443118-71-5 | EM SÍNTESE | |
| Axitinib Impurity 39 | 31913-93-6 | EM SÍNTESE | |
| Axitinib Impurity 4 | 1443118-72-6 | EM SÍNTESE | |
| Axitinib impurity 46 | 261953-36-0 | EM SÍNTESE | |
| Axitinib impurity 47 | 1639137-80-6 | EM SÍNTESE | |
| Axitinib Impurity 50 | 161265-03-8 | EM SÍNTESE | |
| Axitinib Impurity 6 | 1428728-83-9 | EM SÍNTESE | |
| Axitinib Impurity 7 | 944835-85-2 | EM SÍNTESE | |
| Axitinib Impurity 8 | 885126-34-1 | EM SÍNTESE | |
| Axitinib Impurity N1 | 1420478-90-5 | EM SÍNTESE | |
| Axitinib Impurity N2 | 1428728-84-0 | EM SÍNTESE | |
| Axitinib Impurity N3 | 885520-24-1 | EM SÍNTESE | |
| Axitinib Impurity N7 | 2242852-05-5 | EM SÍNTESE | |
| Axitinib Impurity N8 | 1443118-73-7 | EM SÍNTESE |
Prices are quoted per enquiry — pack size, documentation and shipping are confirmed together.
Metabolites, NDSRI nitrosamines and degradation products of Axitinib that no catalogue lists — typically 3–4 weeks from 10 mg to gram scale, released with the same certificate.
—